• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019 - 2021年阿联酋帕金森病在阿联酋人和外籍人口中的前两年观察性探索性真实生活临床表型及社会影响研究:EmPark研究

First Two-Year Observational Exploratory Real Life Clinical Phenotyping, and Societal Impact Study of Parkinson's Disease in Emiratis and Expatriate Population of United Arab Emirates 2019-2021: The EmPark Study.

作者信息

Metta Vinod, Ibrahim Huzaifa, Loney Tom, Benamer Hani T S, Alhawai Ali, Almuhairi Dananir, Al Shamsi Abdulla, Mohan Sneha, Rodriguez Kislyn, Mohan Judith, O'Sullivan Margaret, Muralidharan Neha, Al Mazrooei Sheikha, Dar Mousa Khadeeja, Chung-Faye Guy, Mrudula Rukmini, Falup-Pecurariu Cristian, Rodriguez Bilazquez Carmen, Matar Maryam, Borgohain Rupam, Chaudhuri K Ray

机构信息

Psychology & Neuroscience, Department of Neurosciences, Institute of Psychiatry, King's College London, London, UK.

Parkinson's Foundation Centre of Excellence, King's College Hospital, London, UK.

出版信息

J Pers Med. 2022 Aug 9;12(8):1300. doi: 10.3390/jpm12081300.

DOI:10.3390/jpm12081300
PMID:36013249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9410099/
Abstract

BACKGROUND

Phenotypic differences in Parkinson's Disease (PD) among locals (Emiratis) and Expatriates (Expats) living in United Arab Emirates have not been described and could be important to unravel local aspects of clinical heterogenicity of PD pointing towards genetic and epigenetic variations.

OBJECTIVE

To investigate the range and nature of motor and nonmotor clinical presentations of PD and its impact on time to diagnosis, local service provisions, and quality of life in Emiratis and Expats in UAE, as well as address the presence of current unmet needs on relation to care and etiopathogenesis of PD related to possible genetic and epigenetic factors.

METHODS

a cross-sectional one point in time prospective, observational real-life study of 171 patients recruited from PD and Neurology clinics across United Arab Emirates from 2019-2021. Primary outcomes were sociodemographic data, motor and nonmotor symptoms (NMS), including cognition and sleep, and quality of life (QOL) assessments, Results: A total of 171 PD patients (52 Emiratis 119 Expats) were included with mean age (Emiratis 48.5 (13.1) Expats 64.15 (13.1)) and mean disease duration (Emiratis 4.8 (3.2) Expats 6.1 (2.9)). In the Emiratis, there was a significant mean delay in initiating treatment after diagnosis (Emiratis 1.2 (0.9) Expats 1.6 (1.1)), while from a clinical phenotyping aspect, there is a high percentage of akinesia 25 (48.1) or tremor dominant (22 (42.3)) phenotypes as opposed to mixed subtype 67 (56.3) in Expat cohorts; double tremor dominant, especially Emirati females (25%), had a predominant lower limb onset PD. Both Emirati (27.9 (24.0)) and Expat 29.4 (15.6) showed moderate NMS burden and the NMS profile is dominated by Sleep, Fatigue, Mood, Emotional well-being 3.0 (1.1) and Social Stigma 3.5 (0.9) aspects of PDQ8 SI measurements are predicted worse QOL in Emiratis, while lack of social support 2.3 (1.3) impaired QOL in Expat population. Awareness for advanced therapies was low and only 25% of Emiratis were aware of deep brain surgery (DBS), compared to 69% Expats. Only 2% of Emiratis, compared to 32% of Expats, heard of Apomorphine infusion (CSAI), and no (0%) Emiratis were aware of intrajejunal levodopa infusion (IJLI), compared to 13% of expats.

CONCLUSION

Our pilot data suggest clinical phenotypic differences in presentation of PD in Emiratis population of UAE compared to expats. Worryingly, the data also show delayed treatment initiation, as well as widespread lack of knowledge of advanced therapies in the Emirati population.

摘要

背景

居住在阿拉伯联合酋长国的当地居民(阿联酋人)和外籍人士中帕金森病(PD)的表型差异尚未得到描述,而这对于揭示PD临床异质性的当地情况、指向基因和表观遗传变异可能具有重要意义。

目的

调查阿联酋当地居民和外籍人士中PD运动和非运动临床表现的范围及性质,及其对诊断时间、当地服务提供情况和生活质量的影响,并探讨与可能的基因和表观遗传因素相关的PD护理和病因学方面当前未满足需求的存在情况。

方法

一项横断面的、在一个时间点进行的前瞻性、观察性现实生活研究,研究对象为2019年至2021年从阿联酋各地的PD和神经科诊所招募的171名患者。主要结局包括社会人口统计学数据、运动和非运动症状(NMS),包括认知和睡眠,以及生活质量(QOL)评估。结果:共纳入171名PD患者(52名阿联酋人,119名外籍人士),平均年龄(阿联酋人48.5(13.1),外籍人士64.15(13.1))和平均病程(阿联酋人4.8(3.2),外籍人士6.1(2.9))。在阿联酋人中,诊断后开始治疗的平均延迟时间显著更长(阿联酋人1.2(0.9),外籍人士1.6(1.1)),而从临床表型方面来看,与外籍人士队列中混合亚型占67(56.3)%相比,阿联酋人中有高比例的运动不能型(25(48.1)%)或震颤为主型(22(42.3)%)表型;双震颤为主型,尤其是阿联酋女性(25%),下肢起病的PD占主导。阿联酋人(27.9(24.0))和外籍人士(29.4(15.6))均显示出中度的NMS负担,且NMS概况以睡眠、疲劳、情绪、情感幸福感3.0(1.1)和社会污名3.5(0.9)为主,PDQ8 SI测量的这些方面在阿联酋人中预示着更差的生活质量,而缺乏社会支持2.(1.3)在外籍人群中损害了生活质量。对先进疗法的知晓率较低,只有25%的阿联酋人知晓深部脑刺激术(DBS),相比之下外籍人士为69%。只有2%的阿联酋人听说过阿扑吗啡输注(CSAI),相比之下外籍人士为32%,且没有(0%)阿联酋人知晓空肠内左旋多巴输注(IJLI),相比之下外籍人士为13%。

结论

我们的初步数据表明,与外籍人士相比,阿联酋当地居民中PD的临床表现存在临床表型差异。令人担忧的是,数据还显示治疗开始延迟,以及阿联酋人群中对先进疗法普遍缺乏了解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe2f/9410099/564e6e15d777/jpm-12-01300-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe2f/9410099/433d20d0d24a/jpm-12-01300-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe2f/9410099/62e33a25f623/jpm-12-01300-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe2f/9410099/564e6e15d777/jpm-12-01300-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe2f/9410099/433d20d0d24a/jpm-12-01300-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe2f/9410099/62e33a25f623/jpm-12-01300-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe2f/9410099/564e6e15d777/jpm-12-01300-g003.jpg

相似文献

1
First Two-Year Observational Exploratory Real Life Clinical Phenotyping, and Societal Impact Study of Parkinson's Disease in Emiratis and Expatriate Population of United Arab Emirates 2019-2021: The EmPark Study.2019 - 2021年阿联酋帕金森病在阿联酋人和外籍人口中的前两年观察性探索性真实生活临床表型及社会影响研究:EmPark研究
J Pers Med. 2022 Aug 9;12(8):1300. doi: 10.3390/jpm12081300.
2
EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.欧洲神经内科学杂志 2 期:帕金森病的丘脑下刺激、阿朴吗啡和左旋多巴输注。
Mov Disord. 2019 Mar;34(3):353-365. doi: 10.1002/mds.27626. Epub 2019 Feb 4.
3
EuroInf: a multicenter comparative observational study of apomorphine and levodopa infusion in Parkinson's disease.欧洲信息网络:一项关于阿扑吗啡和左旋多巴输注治疗帕金森病的多中心比较观察性研究。
Mov Disord. 2015 Apr;30(4):510-6. doi: 10.1002/mds.26067. Epub 2014 Nov 10.
4
Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.帕金森病空肠内左旋多巴输注:一项关于对非运动症状和生活质量影响的多中心试点研究
Mov Disord. 2009 Jul 30;24(10):1468-74. doi: 10.1002/mds.22596.
5
Health-related quality of life in early Parkinson's disease: the impact of nonmotor symptoms.早期帕金森病患者的健康相关生活质量:非运动症状的影响。
Mov Disord. 2014 Feb;29(2):195-202. doi: 10.1002/mds.25664. Epub 2013 Oct 7.
6
European Academy of Neurology/Movement Disorder Society-European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies.欧洲神经病学学会/运动障碍学会-欧洲分部关于帕金森病治疗的指南:I. 侵袭性治疗。
Mov Disord. 2022 Jul;37(7):1360-1374. doi: 10.1002/mds.29066. Epub 2022 Jul 6.
7
Evaluation of Self-Assessed State of Health and Vitamin D Knowledge in Emirati and International Female Students in United Arab Emirates (UAE).阿联酋(UAE)阿联酋和国际女学生自我评估健康状况及维生素D知识的评估
Front Psychol. 2020 Jun 12;11:1236. doi: 10.3389/fpsyg.2020.01236. eCollection 2020.
8
Beneficial nonmotor effects of subthalamic and pallidal neurostimulation in Parkinson's disease.丘脑底核和苍白球神经刺激对帕金森病的有益非运动效应。
Brain Stimul. 2020 Nov-Dec;13(6):1697-1705. doi: 10.1016/j.brs.2020.09.019. Epub 2020 Oct 7.
9
Profile of Nonmotor Symptoms and the Association with the Quality of Life of Parkinson's Disease Patients in Nigeria.尼日利亚帕金森病患者的非运动症状概况及其与生活质量的关联
Niger Med J. 2019 Sep-Oct;60(5):273-278. doi: 10.4103/nmj.NMJ_119_19. Epub 2019 Nov 26.
10
Impact of Non-Motor Symptoms on Quality of Life in Patients with Early-Onset Parkinson's Disease.非运动症状对早发性帕金森病患者生活质量的影响。
Can J Neurol Sci. 2024 Sep;51(5):650-659. doi: 10.1017/cjn.2023.336. Epub 2024 Jan 5.

引用本文的文献

1
Test, track, treat using wearable sensors for management of Parkinson's disease: 12‑month prospective observational United Arab Emirates study using Parkinson's Kinetograph (EmPark-PKG Study).使用可穿戴传感器进行帕金森病管理的检测、追踪、治疗:在阿拉伯联合酋长国进行的为期12个月的帕金森病动态监测仪前瞻性观察研究(EmPark-PKG研究)
J Neural Transm (Vienna). 2025 Apr;132(4):591-601. doi: 10.1007/s00702-024-02873-0. Epub 2024 Dec 27.
2
The first cross-sectional comparative observational study of sexual dysfunction in Emirati and non-Emirati Parkinson's disease patients (EmPark-SD) in the United Arab Emirates.阿联酋埃米尔国和非埃米尔国帕金森病患者性障碍的首次横断面对比观察研究(EmPark-SD)。
Sci Rep. 2024 Nov 21;14(1):28845. doi: 10.1038/s41598-024-79668-6.
3

本文引用的文献

1
Young Onset Parkinson's Disease: A Modern and Tailored Approach.早发型帕金森病:一种现代且个性化的治疗方法。
J Parkinsons Dis. 2020;10(s1):S29-S36. doi: 10.3233/JPD-202135.
2
Parkinson's disease in the MENASA countries.中东和北非地区的帕金森病
Lancet Neurol. 2020 Apr;19(4):293-294. doi: 10.1016/S1474-4422(20)30026-0. Epub 2020 Mar 10.
3
Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson's disease: a multi-country Delphi-panel approach.
A 12-month prospective real-life study of opicapone efficacy and tolerability in Emirati and non-White subjects with Parkinson's disease based in United Arab Emirates.在阿拉伯联合酋长国开展的为期 12 个月的前瞻性真实生活研究,评估opicapone 在阿联酋和非白种帕金森病患者中的疗效和耐受性。
J Neural Transm (Vienna). 2024 Jan;131(1):25-30. doi: 10.1007/s00702-023-02700-y. Epub 2023 Oct 5.
在运动障碍专家中就识别和管理晚期帕金森病的临床指标达成共识:一项多国德尔菲小组方法。
Curr Med Res Opin. 2018 Dec;34(12):2063-2073. doi: 10.1080/03007995.2018.1502165. Epub 2018 Aug 20.
4
Short- and long-term cost and utilization of health care resources in Parkinson's disease in the UK.英国帕金森病的短期和长期医疗资源成本和利用情况。
Mov Disord. 2018 Jul;33(6):974-981. doi: 10.1002/mds.27302. Epub 2018 Mar 30.
5
The Parkinson Pandemic-A Call to Action.帕金森病大流行——行动呼吁
JAMA Neurol. 2018 Jan 1;75(1):9-10. doi: 10.1001/jamaneurol.2017.3299.
6
Personalized medicine in Parkinson's disease: Time to be precise.帕金森病的个性化医疗:是时候做到精准了。
Mov Disord. 2017 Aug;32(8):1147-1154. doi: 10.1002/mds.27027. Epub 2017 Jun 12.
7
New concepts in the pathogenesis and presentation of Parkinson's disease.帕金森病发病机制与临床表现的新观念
Clin Med (Lond). 2016 Aug;16(4):365-70. doi: 10.7861/clinmedicine.16-4-365.
8
Parkinson Symptoms and Health Related Quality of Life as Predictors of Costs: A Longitudinal Observational Study with Linear Mixed Model Analysis.帕金森症状及与健康相关的生活质量作为成本预测因素:一项采用线性混合模型分析的纵向观察研究。
PLoS One. 2015 Dec 23;10(12):e0145310. doi: 10.1371/journal.pone.0145310. eCollection 2015.
9
Parkinson's Disease in Saudi Patients: A Genetic Study.沙特患者的帕金森病:一项遗传学研究。
PLoS One. 2015 Aug 14;10(8):e0135950. doi: 10.1371/journal.pone.0135950. eCollection 2015.
10
King's Parkinson's disease pain scale, the first scale for pain in PD: An international validation.国王帕金森病疼痛量表,首个帕金森病疼痛量表:一项国际验证研究。
Mov Disord. 2015 Oct;30(12):1623-31. doi: 10.1002/mds.26270. Epub 2015 Jun 11.